Laparoscopy And Endoscopy Devices Global Market Report 2025

The laparoscopy and endoscopy devices market size has grown strongly in recent years. It will grow from $24.19 billion in 2024 to $25.72 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth during the historic period can be attributed to the rising adoption of minimally invasive surgeries, increased awareness among patients and surgeons regarding shorter recovery times, a growing prevalence of gastrointestinal and urological disorders, the expansion of healthcare infrastructure in emerging markets, and an aging population with a higher incidence of chronic conditions.

The laparoscopy and endoscopy devices market size is expected to see strong growth in the next few years. It will grow to $32.58 billion in 2029 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to the increasing demand for image-guided systems, the expansion of tele-endoscopy and remote surgical capabilities, a rise in surgical procedures following post-COVID-19 recovery, greater adoption in emerging healthcare markets, and regulatory support for minimally invasive technologies. Key trends expected during this period include the development of compact and portable endoscopic systems, integration of augmented reality (AR) for enhanced surgical visualization, growing preference for single-use and disposable endoscopy devices, a shift toward hybrid operating rooms, and the use of artificial intelligence for real-time diagnostic support.

The increasing number of surgical procedures is expected to drive the growth of the laparoscopy and endoscopy devices market in the coming years. Surgical procedures involve medical operations that use operative techniques to diagnose, treat, or manage various health conditions by physically modifying tissues or organs. This rise in surgical procedures is largely due to the growing prevalence of chronic diseases and aging populations, which require more frequent and complex medical treatments. Laparoscopy and endoscopy devices provide real-time, high-resolution imaging of internal organs during surgery through small incisions or natural openings, enabling precise, minimally invasive interventions with reduced trauma, fewer complications, and faster recovery times. For example, in March 2023, the British Association of Aesthetic Plastic Surgeons reported that 31,057 cosmetic surgeries were performed in the UK in 2022, reflecting a significant 102% increase from the previous year. This surge in surgical procedures is contributing to the expanding demand for laparoscopy and endoscopy devices.

Leading companies in the laparoscopy and endoscopy devices market are focusing on the development of advanced technologies, such as 3D fluorescence laparoscopic systems, to enhance surgical visualization and improve outcomes in minimally invasive procedures. A 3D fluorescence laparoscopic system is a cutting-edge imaging solution that combines three-dimensional visualization with fluorescence imaging, enabling greater precision and improved tissue differentiation during surgery. For example, in May 2023, B. Braun SE, a Germany-based medical technology company, introduced the AESCULAP EinsteinVision 3 FI. This innovative system incorporates real-time fluorescence imaging using indocyanine green (ICG) technology, enabling surgeons to clearly identify anatomical structures such as blood vessels, bile ducts, and sentinel lymph nodes. Featuring improved image clarity, an anti-fog function, and a high-resolution stereo endoscope, the system is designed to enhance intraoperative decision-making, reduce surgery time, and improve clinical outcomes in complex minimally invasive procedures.

In September 2024, Spectra Medical Devices, LLC, a US-based medical device company, acquired XL Precision Technologies Ltd. for an undisclosed sum. The acquisition is intended to enhance Spectra’s development and manufacturing capabilities by incorporating XL-PT’s specialization in precision micro-components and complex tubular components. This move strengthens Spectra’s position as a leading contract development and manufacturing organization (CDMO) serving medical device original equipment manufacturers (OEMs). XL Precision Technologies Ltd. is a UK-based manufacturer of medical equipment, including endoscopy and laparoscopy devices.

Major players in the laparoscopy and endoscopy devices market are Johnson & Johnson, Medtronic Plc, FUJIFILM Holdings Corporation, Stryker Corporation, Boston Scientific Corporation, Braun Melsungen AG, Olympus Corporation, Smith & Nephew plc, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., STERIS plc, Arthrex Inc., Karl Storz GmbH & Co. KG, Cook Medical, CONMED Corporation, Ambu A/S, Richard Wolf GmbH, Pentax Medical, SonoScape Medical Corp., CapsoVision Inc., XION Medical GmbH.

North America was the largest region in the laparoscopy and endoscopy devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in laparoscopy and endoscopy devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the laparoscopy and endoscopy devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Laparoscopy and endoscopy devices are advanced minimally invasive instruments used by medical professionals to visually inspect, diagnose, and treat internal organs and cavities through small incisions or natural body openings. These devices utilize modern imaging and access technologies to enable accurate procedures with reduced patient trauma and faster recovery times.

The primary product categories within this market are laparoscopy devices and endoscopy devices. Laparoscopy devices are specialized tools used in minimally invasive surgeries to explore, diagnose, and treat conditions within the abdominal or pelvic regions through small incisions, typically guided by a camera and surgical instruments. The technologies used include conventional endoscopy, robotic-assisted endoscopy, and capsule endoscopy. These devices are applied in various surgical procedures, such as gastrointestinal, cardiac, gynecological, orthopedic, urologic, and neurological surgeries. They are utilized across different healthcare settings, including hospitals, ambulatory surgery centers (ASCs), and other medical facilities.

The laparoscopy and endoscopy devices market research report is one of a series of new reports that provides laparoscopy and endoscopy devices market statistics, including laparoscopy and endoscopy devices industry global market size, regional shares, competitors with a laparoscopy and endoscopy devices market share, detailed laparoscopy and endoscopy devices market segments, market trends and opportunities, and any further data you may need to thrive in the laparoscopy and endoscopy devices industry. This laparoscopy and endoscopy devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The laparoscopy and endoscopy devices market includes sales of energy devices, navigation and tracking systems, specimen retrieval bags, fluid management systems, advanced insufflation systems, electrosurgical instruments, digital documentation systems, sterilization containers and trays, and training simulators. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.